Technical Data
P3105-31A
Papilloma Virus, Human, Type 16 L1, Late Protein (hPV)
Description:
L1 is a major capsid protein of type 16 human papilloma virus. Infection with specific types of HPV has been associated with an increased risk of developing cervical neoplasia. HPV types 6 and 11 have been associated with relatively benign diseases such as genital warts but types 16 and 18 are strongly associated with cervical, vaginal and vulvar malignancies.

Applications:
Suitable for use in ELISA. Other applications not tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG2b5i81Affinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceMouse
Concentration:
~0.2mg/ml
Immunogen:
Recombinant Late 1 (L1) capsid protein from the HPV.
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a liquid in 0.1M Tris-HCl, pH 7.5.
Specificity:
Recognizes a conformational epitope of Papilloma Virus, Human, Type 16 L1, Late Protein (hPV).
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Sasagawa, et al., Virology 206: 126-135 (1995). 2. PNAS USA 89: 12,180-12,184 (1992).